Greengage, a fully-integrated financial services group bridging traditional fiat currency banking services with the emerging digital asset sector, today announced its acquisition of Silver Lined Solutions Limited (SLS). SLS is one of the most highly rated Salesforce consultancy partners in the financial services space and has been actively engaged in building a differentiated core IT architecture for Greengage. Silver Lined Solutions will now be rebranded as Greengage Solutions Ltd (GGS). As a fintech specialist practice, SLS has developed key components to support Greengage in deploying its native risk management, compliance, HR and customer support solutions. Linked to a consolidated Enterprise

FFL Partners (FFL), a private equity firm focused on growth investments in middle market companies, has made an investment in Perlman Clinic, an independent provider of primary care in the Greater San Diego Market. Financial terms of the private transaction have not been disclosed. Perlman Clinic is a full-service provider of comprehensive best-in-class primary care, as well as urgent care, behavioural health, and wellness services. The Company has both fee-for-service and capitated primary care contracts with health plans in Southern California.  Founded in 2005, Perlman Clinic operates 16 facilities staffed by over 100 primary care providers across the Greater San

Eagle Merchant Partners (Eagle), an Atlanta-based private equity firm specialising in franchise, multi-unit consumer and industrial middle market opportunities, has made an investment in Enviro-Master Services. A franchisor of deep cleaning services, Enviro-Master serves tens of thousands of businesses across North America. Its expertise in the health and safety industry and the techniques developed by the company helps to protects its clients and communities against the spread of dangerous bacteria and pathogens, including COVID-19.  Enviro-Master Services represents the tenth franchise investment made by Eagle and its principals. It has made several strategic investments in franchisors, franchisees and corporate owned multi-unit

Soter Analytics (Soter), a global ergonomic technology company, has secured $12 million of new capital in its latest funding round led by AV8 Ventures. OTB Ventures, btov Industrial Technologies Fund and Verve Ventures also participated, along with previous backer Startup Wise Guys. The investment will help drive expansion plans and further research and development in the Company’s smart technology solutions which helps organisations keep their workers safe. 

RoadSafe Traffic Systems, a US-based provider of traffic control and pavement marking services, has acquired North Valley Barricade, it’s sixth acquisition since entering into a partnership with private equity firms Investcorp and Trilantic North America in April 2021. Based in Yuba City, California, NVB retails traffic control products and other construction safety goods throughout the northern California region.

Circularity Capital has continued to build its portfolio of European growth stage businesses enabling the circular economy, by leading a €19 million growth capital round in REBIKE. REBIKE has simultaneously raised €5 million in debt, contributing to a €24 million financing round in total.   A specialist in premium eBike rental and remanufacturing, German-headquartered REBIKE operates an eBike refurbishment process in-house, working hand-in-hand with its rental and subscription solution. Delivered through its proprietary in-house refurbishment facilities, REBIKE enables customers to purchase pre-loved eBikes in ‘as new’ condition – with mechanical parts replaced and electronic parts, such as the battery and

Be Biopharma (Be Bio), a specialist in the discovery and development of Engineered B Cell Medicines (BeCM), has closed a $130 million Series B financing round led by Arch Venture Partners. Bristol Myers Squibb and other new investors also particpated, alongside existing investors including Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund and Takeda Ventures. The round brings the total investment in the Company to date to over $180 million.  The proceeds will advance Be Bio’s proprietary autologous and allogeneic BeCM platforms across multiple therapeutic areas and progress pipeline candidates toward the clinic.